why choose us

First received: November 5, 2022

Clinical Trial: Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure

Study Status: Completed

Recruit Status: Completed

Condition: Chronic Heart Failure

Study Type: Observational


Official Title: A Pre-post Analysis of Healthcare Resource Utilization and Costs of Care in a New User Cohort of Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure

Brief Summary: This study evaluated changes in healthcare resource utilization (HCRU) and costs of care within 12 months following initiation of sacubitril/valsartan (sac/val) in commercially insured and Medicare Advantage (MA) lives in the U.S among adult patients with heart failure with reduced ejection fraction (HFrEF) (cohort 1) and adult patients with chronic heart failure (CHF) (cohort 2).

Read more